Navigation Links
NADDI and the C.A.R.E.S. Alliance Join Attorney General Bondi in Fight Against Prescription Drug Abuse
Date:8/16/2011

TALLAHASSEE, Fla., Aug. 16, 2011 /PRNewswire-USNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) and the C.A.R.E.S. (Collaborating and Acting Responsibly to Ensure Safety) Alliance(SM) have joined Attorney General Pam Bondi in addressing a serious public health issue in Florida – prescription drug abuse. Attorney General Bondi sponsored a proclamation today that makes August 27 a statewide Drug Take Back Day. NADDI and the C.A.R.E.S. Alliance are co-sponsoring the Take Back Day and invite Floridians to fight prescription drug abuse by safely disposing of unused prescription drugs at specified locations.

NADDI, an organization that focuses on drug diversion activities, has long supported drug take back initiatives. In their efforts to address the growing problem of abuse and misuse, the organization shares investigative information and works with a wide variety of organizations and law enforcement on pharmaceutical drug diversion. NADDI recently joined the C.A.R.E.S. Alliance, a coalition of ten national patient safety, provider and drug diversion organizations focused on reducing opioid pain medication abuse and increasing responsible prescribing habits.

In addition to co-sponsoring the Florida statewide Drug Take Back Day, the C.A.R.E.S. Alliance has ongoing programs and initiatives throughout the country focused on curbing prescription drug diversion, abuse and misuse. The coalition's comprehensive website (www.caresalliance.org) includes information for physicians, pharmacists, patients and their families. Physicians and pharmacists can find tools for prescribing, screening and assessing patients, and patients and their families can find tips for the safe use and handling of their medications.

The C.A.R.E.S. Alliance was created in response to the devastating impact prescription drug abuse and misuse has on communities throughout the country. According to the Centers for Disease Control and Prevention, prescription drug overdoses killed seven Floridians per day in 2009. The C.A.R.E.S. Alliance and NADDI believe that national, state and local cooperation is critical in bending the curve of abuse in Florida and across the country.  

"We all play a role in combating abuse and misuse and improving patient and public safety," said the C.A.R.E.S. Alliance representative Herbert Neuman, M.D., Vice President of Medical Affairs and Chief Medical Officer – Pharmaceuticals for Covidien. "A successful long-term solution can be found, but only through collaboration with groups like NADDI, more focused community education and better resources for prescribers and pharmacists."

Charlie Cichon, Executive Director of NADDI, agrees with the C.A.R.E.S. Alliance's focus on collaboration. "It is unique partnerships like these that really make a difference. We believe that collaboration through this initiative and others will further our progress against illegal diversion of legitimate, prescription medicines."

On August 27, through a unique partnership, more than 70 pharmacies and law enforcement offices throughout Florida will participate in the Drug Take Back Day and will be accepting unused medications. To identify your community partners and to find the drop off site nearest you, please visit www.projectdrugdrop.com or www.caresalliance.org.

About the C.A.R.E.S. Alliance

Launched in September 2010, the C.A.R.E.S. Alliance is a coalition of ten national patient safety, provider and drug diversion organizations focused on reducing opioid pain medication abuse and increasing responsible prescribing habits. The C.A.R.E.S. Alliance was created by Covidien, a pharmaceutical manufacturer, to ensure the safe use of all medications by collaboratively developing and sharing tools and resources for all stakeholders.  

About NADDI

The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.


'/>"/>
SOURCE National Association of Drug Diversion Investigators (NADDI)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
2. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
3. Lung Cancer Alliance Commends NCCN on Screening Guidelines
4. Lung Cancer Alliance Hails Announcement of New Erbitux(R) Data
5. Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
6. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
7. Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
8. ICON and MedAvante Sign Alliance Agreement
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
11. SIRO Clinpharm and CambReg Ltd Strategic Alliance to Offer Regulatory Services in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):